Search results for " Need"

showing 10 items of 648 documents

COVID-19 and tuberculosis - threats and opportunities

2020

Pulmonary and Respiratory Medicine2019-20 coronavirus outbreakEconomic growthTuberculosisCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralInternational Health RegulationsGlobal HealthInternational Health RegulationsBetacoronavirusPandemicGlobal healthMedicineHumansPandemicsTuberculosis PulmonaryHealth Services Needs and Demandbusiness.industryCoinfectionSARS-CoV-2COVID-19medicine.diseaseCoronavirusInfectious DiseasesCommunicable Disease ControlbusinessCoronavirus InfectionsCoronavirus Infections
researchProduct

Mediastinal lymph node staging with transesophageal echography in cancer of the lung.

1990

Transesophageal echography (TEE) was used prospectively to study mediastinal lymph node enlargement in 23 patients with cancer of the lung. The findings were validated blindly by comparison with computed tomography (CT, n = 23) and pathological N classification after curative surgery (n = 9). Lymph nodes larger than 1 cm were defined as pathologically enlarged. In the upper mediastinum, 22% (8 vs 36), in the lower mediastinum including the subaortic region 112% (37 vs 33) and in the hilar region 67% (6 vs 9) of enlarged lymph nodes diagnosed by CT were detected by TEE. A pathological study in 9 patients demonstrated true positive findings in 2 vs 1, true negatives in 4 vs 5, false positives…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyLung NeoplasmsSensitivity and SpecificityAortopulmonary windowEsophagusBronchoscopymedicineCarcinomaHumansProspective StudiesLung cancerAgedNeoplasm StagingUltrasonographyLungbusiness.industryBiopsy NeedleMediastinumGeneral MedicineMiddle Agedmedicine.diseasemedicine.anatomical_structureGreat vesselsEvaluation Studies as TopicMediastinal lymph nodeLymphatic MetastasisSurgeryFemaleRadiologyLymphCardiology and Cardiovascular MedicinebusinessTomography X-Ray ComputedEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
researchProduct

Palliative Care Needs and Integration of Palliative Care Support in COPD

2021

Background The provision of palliative care for severe COPD remains low, resulting in unmet needs in patients and carers. Research Questions What are the palliative care needs of patients living with severe COPD and their caregivers? What views of accessing and providing palliative care and factors influence these experiences. To what extent have palliative care and COPD services been integrated? Study Design and Methods A multicentre qualitative study was undertaken in COPD services and specialist palliative care in the United Kingdom involving patients with severe COPD, their carers, and health professionals. Data were collected using semistructured interviews and were analyzed using fram…

Pulmonary and Respiratory MedicineCOPDeducation.field_of_studyPalliative careConstant comparisonbusiness.industryData synthesisPopulationCritical Care and Intensive Care Medicinemedicine.disease3. Good healthUnmet needs03 medical and health sciences0302 clinical medicine030228 respiratory systemNursingNeeds assessmentmedicine030212 general & internal medicineCardiology and Cardiovascular MedicineeducationbusinessQualitative researchChest
researchProduct

Pleuropulmonary changes induced by ergoline drugs.

1996

Classic ergolines, such as bromocriptine, methysergide and ergotamine, can induce chronic pleuropneumonitis. We present the cases of eight patients who developed similar changes whilst on other ergolines. In this retrospective case study spanning 1985-1995, clinical data, radiological material, pulmonary function, bronchoalveolar lavage and histopathology were reviewed. Earlier literature on ergoline-induced pleuropulmonary changes was reviewed. Eight middle-aged to elderly individuals of both sexes developed pleuropulmonary changes during long-term therapy with regular dosages of nicergoline (n = 4), dihydroergocristine (n = 3), or dihydroergotamine (n = 1). Bibasilar pleural thickening wi…

Pulmonary and Respiratory MedicineLung DiseasesMalePleural effusionDihydroergotamineDihydroergocristineBronchoalveolar LavagePleural diseasemedicineHumansErgolinesAgedAged 80 and overmedicine.diagnostic_testbusiness.industryRespiratory diseaseBiopsy NeedleMiddle AgedPleural Diseasesmedicine.diseasePrognosisNicergolineRespiratory Function TestsSurvival RateBronchoalveolar lavageEffusionAnesthesiaFemalebusinessLung Diseases InterstitialTomography X-Ray Computedmedicine.drugThe European respiratory journal
researchProduct

New organisation for follow-up and assessment of treatment efficacy in sleep apnoea.

2019

Obstructive sleep apnoea (OSA) is a highly prevalent disease, and there is an increased demand for OSA diagnosis and treatment. However, resources are limited compared with the growing needs for OSA diagnosis and management, and alternative strategies need to be developed to optimise the OSA clinical pathway. In this review, we propose a management strategy for OSA, and in general for sleep-disordered breathing, to be implemented from diagnosis to follow-up. For this purpose, the best current options seem to be: 1) networking at different levels of care, from primary physicians to specialised sleep laboratories; and 2) use of telemedicine. Telemedicine can contribute to the improved cost-ef…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyTelemedicineRespiratory TherapyMEDLINEPredictive Value of TestDiseaseSettore MED/10 - Malattie Dell'Apparato Respiratorio03 medical and health sciencesSleep Apnea Syndrome0302 clinical medicineClinical pathwaySleep Apnea SyndromesPredictive Value of TestsPositive airway pressureMedicineHumansIntensive care medicineLunglcsh:RC705-779Health Services Needs and Demandbusiness.industryDelivery of Health Care IntegratedRespirationlcsh:Diseases of the respiratory systemRecovery of FunctionTreatment efficacyTelemedicinenervous system diseasesrespiratory tract diseasesManagement strategyTreatment Outcome030228 respiratory systemPatient ComplianceSleep (system call)businessSleep030217 neurology & neurosurgeryNeeds AssessmentHumanEuropean respiratory review : an official journal of the European Respiratory Society
researchProduct

Overcoming Barriers to the Effective Management of Severe Asthma in Italy.

2021

Pierluigi Paggiaro,1 Simona Barbaglia,2 Stefano Centanni,3,4 Davide Croce,5 Enrico Desideri,6 Saffi Giustini,7,8 Claudio Micheletto,9 Antonino Musarra,10 Nicola Scichilone,11 Ugo Trama,12 Maria Teresa Zedda,7,13 Giorgio Walter Canonica14 1Department of Surgery, Medicine, Molecular Biology, and Critical Care, University of Pisa, Pisa, Italy; 2Associazione Nazionale Pazienti “Respiriamo Insieme”, Padova, Italy; 3Department of Health Sciences, Università degli Studi di Milano, Milan, Italy; 4Respiratory Unit, ASST Santi Paolo e Carlo, Milan, Italy; 5Center for Health Economics, Social and Health Care Management, LIUC-Università Cattaneo, Castellanza, I…

Pulmonary and Respiratory Medicinesevere asthmaReferralunmet needsSettore MED/10 - Malattie Dell'Apparato Respiratoriooral corticosteroids03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Biologic therapy Expert opinion Oral corticosteroids Severe asthma Unmet needsMultidisciplinary approachHealth careJournal of Asthma and AllergyImmunology and AllergyMedicine0601 history and archaeologybiologic therapyInformation exchange060102 archaeologybusiness.industryMedical record06 humanities and the artsRC581-607medicine.diseaseExpert OpinionIntegrated care030228 respiratory systemMedical emergencyImmunologic diseases. AllergybusinessPatient educationJournal of asthma and allergy
researchProduct

Unmet needs and challenges in gastric cancer: The way forward

2014

AbstractAlthough the incidence of gastric cancer has fallen steadily in developed countries over the past 50years, outcomes in Western countries remain poor, primarily due to the advanced stage of the disease at presentation. While earlier diagnosis would help to improve outcomes for patients with gastric cancer, better understanding of the biology of the disease is also needed, along with advances in therapy. Indeed, progress in the treatment of gastric cancer has been limited, mainly because of its genetic complexity and heterogeneity. As a result, there is an urgent need to apply precision medicine to the management of the disease in order to ensure that individuals receive the most appr…

Quality Controlmedicine.medical_specialtyDrug developmentAuditDiseasePathogenesisMalignancyUnmet needsGastrectomyStomach NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansRadiology Nuclear Medicine and imagingMolecular Targeted TherapyRegistriesIntensive care medicineQuality of Health CareRandomized Controlled Trials as Topicbusiness.industryIncidence (epidemiology)CancerGenomicsGeneral Medicinemedicine.diseasePrecision medicineSurgeryEuropeTreatmentOncologyRadiology Nuclear Medicine and imagingDrug DesignQuality of LifeHeterogeneitybusinessGastric cancerDelivery of Health CareDeveloped countryAlgorithms
researchProduct

Comparison of dental treatment performed under general anesthesia between healthy children and children with special health care needs in a hospital …

2018

Background The aim of this retrospective study was to assess and compare the dental treatments performed under general anesthesia (GA) between healthy children and children with special health care needs (SHCN) according to age group and gender at king Fahd hospital, Dhahran, Saudi Arabia. Material and Methods Data was retrieved from the records of 304 healthy and SHCN children 1 18 years of age who received dental rehabilitation under GA in the period 2015-2018. The dental treatment modalities were compared in the two groups and differences according to age group and gender were reported. Results Compared to healthy children, children with SHCN received significantly less pulp therapy trea…

Radical treatmentRehabilitationHospital settingbusiness.industryResearchmedicine.medical_treatmentChildren with special health care needsMEDLINERetrospective cohort study030206 dentistry:CIENCIAS MÉDICAS [UNESCO]stomatognathic diseases03 medical and health sciences0302 clinical medicinestomatognathic systemAnesthesiaPulp therapyUNESCO::CIENCIAS MÉDICASMedicineOdontostomatology for the Disabled or Special Patients030212 general & internal medicinebusinessGeneral DentistryPermanent teethJournal of Clinical and Experimental Dentistry
researchProduct

Zofenopril is a cost-effective treatment for patients with left ventricular systolic dysfunction following acute myocardial infarction: a pharmacoeco…

2013

Objective: The Survival of Myocardial Infarction Long-term Evaluation 4 Study (SMILE-4) showed the superiority of Zofenopril (Z) associated with Acetylsalicylic Acid (ASA) as respect to Ramipril (R) plus ASA in reducing the occurrence of major cardiovascular events, in patients with left ventricular dysfunction (LVD) following Acute Myocardial Infarction (AMI). The objective of this retrospective analysis was the evaluation of cost-effectiveness of Z compared to R. Methods: 771 patients with LVD and AMI were randomized, double-blind to Z 60 mg/day (n=389) or R 10 mg/day (n=382) plus ASA 100 mg/day and followed-up for 1 year. The primary study end-point was 1-year combined occurrence of deat…

RamiprilPediatricsmedicine.medical_specialtyeducation.field_of_studybusiness.industryCost effectivenessSurrogate endpointPopulationmedicine.diseaseConfidence intervalZofenoprilchemistry.chemical_compoundchemistryInternal medicinemedicineCardiologyNumber needed to treatMyocardial infarctionCardiology and Cardiovascular Medicinebusinesseducationhealth care economics and organizationsmedicine.drugEuropean Heart Journal
researchProduct

Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMI…

2013

Claudio Borghi,1 Ettore Ambrosioni,1 Stefano Omboni,2 Arrigo FG Cicero,1 Stefano Bacchelli,1 Daniela Degli Esposti,1 Salvatore Novo,3 Dragos Vinereanu,4 Giuseppe Ambrosio,5 Giorgio Reggiardo,6 Dario Zava7 1Unit of Internal Medicine, Policlinico S Orsola, University of Bologna, Bologna, Italy; 2Italian Institute of Telemedicine, Varese, Italy; 3Division of Cardiology, University of Palermo, Palermo, Italy; 4University and Emergency Hospital, Bucharest, Romania; 5Division of Cardiology, University of Perugia, Perugia, Italy; 6Mediservice, Milano, Italy; 7Istituto Lusofarmaco d'Italia SpA, Peschiera Borromeo, Italy Background: In SMILE-4 (the Survival of Myocardial Infarction Long-term…

Ramiprilmedicine.medical_specialtyCost effectivenessEconomics Econometrics and Finance (miscellaneous)Populationacute myocardial infarctionramiprilchemistry.chemical_compoundInternal medicinePost-hoc analysismedicinezofenoprilMyocardial infarctioneducationcost-effectivenesshealth care economics and organizationsOriginal Researchleft ventricular dysfunctioneducation.field_of_studylcsh:R5-920business.industryHealth Policylcsh:RM1-950acetylsalicylic acidmedicine.diseaseSMILE studycost effectiveness analysis (CEA)Confidence intervalZofenoprilangiotensin-converting enzyme inhibitorsClinicoEconomics and Outcomes Researchlcsh:Therapeutics. PharmacologychemistryCardiologyNumber needed to treatMedical emergencybusinesslcsh:Medicine (General)medicine.drug
researchProduct